Gan & Lee(SH:603087) Zheng Quan Zhi Xing·2025-05-30 10:59Core Viewpoint - 甘李药业 announced the repurchase and cancellation of certain restricted stocks from its 2022 and 2024 incentive plans, along with adjustments to the repurchase prices [1][10]. Group 1: Repurchase Details - The number of restricted stocks to be repurchased under the 2022 incentive plan is 169,300 shares [1][7]. - The number of restricted stocks to be repurchased under the 2024 incentive plan is 72,000 shares [1][7]. - The repurchase price for the 2022 incentive plan is set at 15.65 yuan per share [1][8]. - The repurchase price for the 2024 incentive plan is set at 18.09 yuan per share [1][8]. Group 2: Reasons for Repurchase - The repurchase is due to 10 individuals from the 2022 incentive plan leaving the company, leading to the cancellation of their stock qualifications [7]. - One individual from the 2024 incentive plan also left, prompting the cancellation of their stock qualifications [7]. - Performance evaluations for some individuals resulted in partial stock repurchases due to unmet performance criteria [7]. Group 3: Impact on Share Structure - After the repurchase, the proportion of restricted shares will be 7.84%, while unrestricted shares will remain at 92.16% [9]. - The total number of shares will decrease from 600,823,990 to 601,065,290 shares post-repurchase [9]. - The repurchase will not change the controlling shareholder or the actual controller of the company [9]. Group 4: Financial Impact - The repurchase of restricted stocks is not expected to have a substantial impact on the company's financial status or operational results [10]. - The management team will continue to fulfill their responsibilities diligently, aiming to create value for shareholders [10]. Group 5: Approval and Legal Compliance - The repurchase plan has been approved by the company's board and supervisory committee [10]. - The funding for the repurchase will come entirely from the company's own funds [10]. - The legal opinions confirm that the repurchase complies with relevant laws and regulations [11].